Real-Time Metabolic Imaging. Made Simple.
On-site, push-button production of metabolic imaging agents

Dynamic metabolite signals are below the detection threshold of standard MRI. POLARIS uses hyperpolarization to enhance these signals by more than 10,000x, transforming existing MRI infrastructure into a real-time, non-invasive metabolic imaging platform.
With POLARIS, metabolic imaging agents are produced on-site, making advanced metabolic imaging simple, reliable, and scalable.
Real-Time Metabolic Imaging in 3 Simple Steps
Prepare

Take a precursor metabolic agent (organic molecule natural to the body), e.g., 13C enriched pyruvate
Polarize

Use POLARIS to amplify the MRI signal of the metabolic agent by >10,000x through spin hyperpolarization
Scan

Inject the hyperpolarized agent and measure its metabolism using standard MRI
POLARIS minimizes variability through standardized kits and automated polarization and purification.
Within 3 minutes, a hyperpolarized dose is ready for injection and imaging.

From system readiness to dose initiation, all steps are managed through a clear, intuitive touchscreen interface.
Explore how POLARIS could fit into your workflow
Key Benefits
- High throughput (up to 3 doses/hour)
- Convenient, room temperature processing
- Small footprint, minimal infrastructure adjustment
- Simple, robust workflow with ready-to-use kits

An End-to-End Solution for Rapid Setup in Your Lab
Polarizer

Consumables
Active Ingredients
Ready-to-use 13C-pyruvate precursor and catalyst

Parahydrogen Cylinders

Support
Service & Maintenance
Consulting & Training
Research Collaborations
Grant Applications
Image Acquisition & Analysis
Obtain High-Quality Hyperpolarized Signal With PHIP
POLARIS uses parahydrogen-induced polarization (PHIP) to produce hyperpolarized metabolic imaging agents. PHIP enables strong, robust signal enhancement for real-time metabolic imaging within a streamlined, high-throughput workflow.
With POLARIS, PHIP produces a metabolic signal comparable to d-DNP.
Data generated by:
Luca Nagel, Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany

1H-MRI
Coronal slice of a subcutaneous MATBIII breast cancer model (rat) surrounded by gel for B0 homogeneity.

PHIP Lac/Pyr
Lactate/pyruvate ratio measured from 3D dynamic bSSFP after injection of PHIP pyruvate.

d-DNP Lac/Pyr
Lactate/pyruvate ratio after injection of d-DNP pyruvate (same location, same sequence as PHIP).

